NCT04267978 2024-10-15
Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Beijing Sanbo Brain Hospital
Phase 2 Recruiting
Clinical Trials
5 trialsNCT05278715 2024-10-15
Modified CV Regimen in Optic Pathway Glioma
Beijing Sanbo Brain Hospital
Phase 2 Recruiting
NCT04356118 2020-05-27
Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Hebei Medical University
Phase 4 Unknown
NCT02104323 2017-02-09
Endostatin
Beijing Tiantan Hospital
Phase 2 Completed
NCT02615106 2016-06-14
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown